Glucose Monitors

Medicare covers home blood glucose monitors, related testing supplies, and continuous glucose monitors (CGMs) when the beneficiary has diabetes and the treating practitioner documents sufficient training, issues a prescription, and meets device‑specific criteria (e.g., FDA indication, insulin treatment or problematic hypoglycemia for CGMs). Coverage includes specified quantities of test strips and lancets (100 per 3 months for non‑insulin users; 300 per 3 months for insulin users) with defined processes for approval of higher utilization, required practitioner visits every six months for CGM continuation, PDAC/PCL verification for certain CGM codes, and supplier documentation requirements (SWO/WOPD, POD, and documented refill requests).

"Beneficiary has diabetes mellitus and the treating practitioner has concluded the beneficiary (or caregiver) has sufficient training using the prescribed device as evidenced by a prescription for a..."